Growth hormone & GHRH Peptides
24 compounds in this group, 2 of them with an FDA-approved product. Grouping follows what each compound is studied or marketed for; it does not mean the use is proven.
All growth hormone & ghrh compounds (A–Z)
| Compound | FDA status | PubMed papers | Last 5 years | Registered trials | Class |
|---|---|---|---|---|---|
| ACE-031 | Investigational (development stopped) | 12 | 5 | 4 | Activin receptor IIB decoy protein |
| CJC-1295 | Not approved (research only) | 35 | 18 | 0 | GHRH analog (with or without DAC) |
| CJC-1295 (no DAC) + ipamorelin | Not approved (research only) | 51 | 12 | 0 | Research blend |
| CJC-1295 (no DAC) + ipamorelin blend | Not approved (research only) | 51 | 12 | 0 | Research blend |
| CJC-1295 + GHRP-2 blend | Not approved (research only) | 15 | 2 | 0 | Research blend |
| CJC-1295 + ipamorelin | Not approved (research only) | 51 | 12 | 0 | Research combination |
| Follistatin | Not approved (research only) | 2,974 | 671 | 15 | Activin-binding glycoprotein |
| Follistatin-315 | Not approved (research only) | 2,974 | 671 | 15 | Follistatin isoform |
| Follistatin-344 | Not approved (research only) | 5 | 1 | 0 | Follistatin precursor isoform |
| GHRH | Natural hormone (analogs approved) | 2,508 | 276 | 95 | Hypothalamic hormone |
| GHRP-2 | Not approved (research only) | 15 | 2 | 0 | Ghrelin-receptor agonist peptide |
| GHRP-6 | Not approved (research only) | 639 | 70 | 0 | Ghrelin-receptor agonist peptide |
| Hexarelin | Not approved (research only) | 291 | 16 | 0 | Ghrelin-receptor agonist peptide |
| HGH fragment 176-191 | Not approved (research only) | 1 | 1 | 0 | Growth hormone fragment |
| IGF-1 LR3 | Not approved (research only) | — | — | 0 | IGF-1 analog |
| Ipamorelin | Not approved (research only) | 51 | 12 | 3 | Selective ghrelin-receptor agonist |
| Ipamorelin + tesamorelin blend | Not approved (research only) | 51 | 12 | 0 | Research blend |
| MGF | Not approved (research only) | 194 | 19 | 105 | IGF-1 splice variant |
| MK-677 | Not approved (research only) | 30 | 19 | 8 | Oral ghrelin-receptor agonist (non-peptide) |
| PEG-MGF | Not approved (research only) | 1 | 1 | 0 | PEGylated MGF |
| Sermorelin | Approved, discontinued | 25 | 15 | 27 | GHRH analog (1-29) |
| Somatropin | FDA-approved | 420 | 155 | 818 | Recombinant growth hormone |
| Tesamorelin | FDA-approved | 95 | 34 | 24 | GHRH analog |
| Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend | Not approved (research only) | 95 | 34 | 0 | Research blend |
Frequently asked questions
Which growth hormone & ghrh peptides are FDA-approved?
2 of the 24 have an FDA-approved product: Somatropin and Tesamorelin. Research-grade vials sold online are not those approved products.
Which growth hormone & ghrh peptides have the most research?
By PubMed records: Follistatin (2,974), Follistatin-315 (2,974) and GHRH (2,508). 7 have fewer than 25 indexed papers, mostly cell or animal work.
Which have registered human trials?
10 appear on ClinicalTrials.gov, led by Somatropin (818), MGF (105), GHRH (95) and Sermorelin (27). ACE-031 is still investigational.
Comparisons
Reconstitution math
CJC-1295 with DAC 5 mg vial mathCJC-1295 with DAC 2 mg vial mathGHRP-6 5 mg vial mathCJC-1295 (no DAC) 5 mg vial mathSomatropin 10 IU vial mathTesamorelin 10 mg vial mathTesamorelin 20 mg vial mathIGF-1 LR3 1 mg vial mathGHRP-2 10 mg vial mathMGF 5 mg vial math
Other categories
Weight loss & GLP-1Tissue repair & recoveryAnti-aging & longevityCognitive, neuro & sleepBlends & stacksSexual & reproductive healthImmune supportBioregulators & other research compounds
Protocol hub: Growth hormone & GHRH protocols and vial math.
Evidence ranking: best hormone optimization peptides.